In a previous study we provided evidence for a circuitous pathway by which circulating plasma proteins enter megakaryocyte granules by an endocytic mechanism and are returned to the circulation in platelets (1987. Proc. NatL. Acad. Sci. USA. 84:861-865). Horseradish peroxidase (40,000 mol wt) was injected into guinea pigs and its uptake into megakaryocyte organelles examined by electron microscopy and cytochemistry.
Recently we demonstrated that when the tracer protein horseradish peroxidase (HRP)' (40,000 mol wt) is injected intravenously into guinea pigs, it is rapidly taken up by bone marrow megakaryocytes and incorporated into granules (14, 15) . Based on this finding, we hypothesized that megakaryocytes may acquire some a-granule proteins from plasma via a similar endocytic pathway.
We undertook the present study to determine whether megakaryocytes could take up albumin (64,000 mol wt), IgG (180,000 mol wt), and fibrinogen (340,000 mol wt) injected intravenously into guinea pigs. We used two experimental approaches to localize the injected protein in the presence of its native counterpart. In the first approach, we injected heterologous human proteins and then detected them immunohistochemically in bone marrow sections using antibodies that did not crossreact with their respective guinea pig counterparts. In the second approach we injected homologous guinea pig proteins labeled with biotin, a small (250 mol wt) inert molecule, and then detected them immunohistochemically using an anti-biotin antibody. We detected all three of the injected proteins in bone marrow megakaryocytes in localization patterns similar to those of their native counterparts.
Methods
Animals. 35 male Hartley guinea pigs, each weighing 400-450 g, were used in the experiments.
Plasma proteins. Human albumin (crystallized) and IgG, purified guinea pig albumin, guinea pig IgG, guinea pig fibrinogen, and lactoferrin (from human milk) were all obtained from Sigma Chemical Co., St. Louis, MO. Human fibrinogen (grade L) was from KabiVitrum, Stockholm, Sweden.
Biotinylation. Plasma proteins were biotinylated by modifying the method of Leary et al. (16) . The protein (10-20 mg/ml) was dialyzed against 1.0 M NaCl/0.03 M N-Tris[hydroxymethyl]methyl-2-aminoethane sulfonic acid, pH 7.42. Biotinyl-epsilon-aminocaproic acid N-hydroxysuccinate ester (50 mg/ml in dimethyl-formamide) was added in a 1:100 dilution (vol/vol), and the mixture was incubated at 20'C for 30 min, then at 4VC for 90 min. All samples were then dialyzed extensively against the NaCl/TES buffer, and finally against 0.15 M NaCl/0.0 I M NaPO4, pH 7.4, at 20°C. All of the biotinylated albumin and fibrinogen migrated as intact proteins on Western immunoblots. No degradation products were detected. In control experiments, biotinyl-epsilon-aminocaproic acid N-hydroxysuccinimide ester in buffer was injected in place of biotinylated protein. The amount of injected biotin was equivalent to the amount oftotal biotin ester incubated with each protein during the biotinylation procedure and therefore was at least as large, or possibly larger, than the amount injected in experiments with the labeled proteins.
Administration ofproteins to guinea pigs. A single dose of human albumin (1 g), human IgG (300 mg), or human fibrinogen (75 mg) was injected into guinea pigs to obtain circulating concentrations similar to native counterparts. In other experiments, smaller doses of human albumin (100 mg), biotinylated guinea pig albumin, biotinylated guinea pig IgG, biotinylated guinea pig fibrinogen, or biotinylated human fibrinogen were injected. The dose of injected biotinylated protein ranged from 30 to 175 mg. To test whether the megakaryocyte uptake of circulating proteins shows specificity, we administered 100 mg of lactoferrin (76,000 mol wt) intravenously to a guinea pig. All proteins were administered in volumes of 5 ml via an indwelling jugular catheter.
Processing of bone marrow. The animals were killed at various times after injection by exsanguination. The vasculature was flushed with heparinized HBSS, immediately followed by fixative (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4) via a catheter in the abdominal aorta. The femoral bone marrow core was cut into small pieces and incubated in the same fixative for 6 h at 40C. The Localization of native plasma proteins in megakaryocytes. Bone marrow from untreated guinea pigs was stained for native albumin, IgG, and fibrinogen using the technique described above. The antibodies used were rabbit anti-guinea pig albumin (2.0 mg/ml, 1:10,000; Cappel Laboratories, Cochranville, PA), rabbit anti-guinea pig IgG (I mg/ml, 1:1,000; Zymed Labs., Inc., San Francisco, CA) and rabbit anti-human fibrinogen antibody (20 mg/ml; 1:500; Cappel Laboratories). The last antibody, although raised against human fibrinogen, recognized guinea pig fibrinogen.
Localization ofinjected proteins
In the first approach, injected human proteins were detected in bone marrow in the presence of their native counterparts by using noncrossreacting antibodies. In the second approach, biotinylated homologous guinea pig proteins were injected. The In all experiments with biotinylated proteins, parallel control experiments were done using bone marrow from untreated guinea pigs and guinea pigs injected with free, unconjugated biotin.
Ultrastructural localization. Biotin-labeled guinea pig albumin (500 mg) was administered intravenously to guinea pigs. Bone marrow megakaryocytes (14) and platelets (18) were isolated as previously described 2 and 24 h after the injection. Cells were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 6 h at 4VC. They were then embedded in LR gold (London Resin Company Ltd., Hampshire, UK) at low temperature according to the manufacturer's instructions. The biotin-labeled albumin was localized by post-embedding immunocytochemistry using the goat anti-biotin antibody (1:100) and HRP-conjugated streptavidin as described above for light microscopy. The reaction product was developed by incubation in 0.05% 3,3' diaminobenzidine and 0.1% H202 in 0.05 M Tris-HCl at pH 7.6. Thin sections were exposed to a 1% aqueous solution of osmium tetroxide and stained for 5 min with Reynold's lead citrate (19) .
In control studies megakaryocytes and platelets isolated from untreated guinea pigs were processed and stained identically. IMMUNOGLOBULIN G Human IgG. Injected human IgG was detected in the presence of native guinea pig IgG using biotinylated goat anti-human IgG (1.5 mg/ml, 1 X 103; Vector Laboratories, Inc.). The 3% crossreactivity with guinea pig IgG exhibited by this antibody was neutralized completely by adsorption against guinea pig serum. As this antibody was biotinylated, incubation with it was followed by incubation with HRP-conjugated streptavidin. No secondary antibody was used. In control studies, bone marrow from untreated animals was stained identically.
Guinea pig IgG. Bone marrow from guinea pigs killed 24 h after being injected with biotinylated IgG was stained with goat anti-biotin antibody as described above.
FIBRINOGEN
Humanfibrinogen. We tested a mouse MAb against human fibrinogen (Serotec Ltd., Bicester, UK) to detect the uptake of injected human fibrinogen.
Biotinylated fibrinogen. Guinea pigs were killed at various time intervals after being injected with biotinylated guinea pig fibrinogen or biotinylated human fibrinogen. The biotinylated protein was localized immunohistochemically in bone marrow using the goat anti-biotin antibody described above.
HUMAN LACTOFERRIN
Bone marrow obtained 24 h after administration of lactoferrin was stained with rabbit anti-human lactoferrin (1 mg/ml, 1:50; Accurate Chemical and Scientific Corporation, Westbury, NY). The control was bone marrow from an untreated animal processed identically.
Detection ofbiotinylatedfibrinogen in circulating platelets by immunoblotting and immunocytochemistry
Blood was drawn from guinea pigs at 2 and 24 h after injection of biotinylated fibrinogen. Platelets were purified and washed by differential centrifugation (18) . Platelets (3 X 109/tube) were then incubated with 10 U of thrombin for 2 min and the supernatant and pellet analyzed for biotinylated fibrinogen. The supernatants were concentrated -2.5-to 5-fold. Samples were solubilized in 2.0% SDS and electrophoresed in SDS-5% polyacrylamide gels (3% stacking gel) at 20 mA/gel. After washing ofthe gel, proteins were transferred to nitrocellulose using a Mini transblot apparatus (Bio-Rad Laboratories, Richmond, CA) at 100 V for 1 h. The nitrocellulose was washed, then blocked with 5% gelatin. The nitrocellulose was then incubated with avidin-peroxidase (Cappel Laboratories) diluted 1:500 for 1 h, washed, and developed using 4-chloro-l-naphthol and H202.
To show that the endocytosed protein was present within a-granules, we colocalized injected labeled fibrinogen and native albumin, a known a-granule protein (3), using a double-labeling technique on frozen thin sections (20). Biotin-labeled fibrinogen was localized using rabbit anti-biotin antibody (Enzo Biochem, Inc., New York, NY) and 5 nM gold probe conjugated to protein A (protein A5; Janssen Pharmaceutica, Beerse, Belgium). Native guinea pig albumin was localized with rabbit anti-guinea pig albumin (Zymed) and 10 nM gold probe conjugated to protein A (protein A10) (Janssen Pharmaceutica). Controls included platelets from untreated guinea pigs processed identically, and substitution of nonimmune rabbit serum for specific primary antibody.
Results
We used antibodies against guinea pig albumin, IgG, and fibrinogen to study the normal distribution of these three proteins in the megakaryocytes of untreated animals. We then used two techniques for immunolocalization of injected albumin, IgG, and fibrinogen in megakaryocytes. The two techniques yielded comparable results in localizing the injected proteins.
Albumin Native albumin. When bone marrow from untreated guinea pigs was stained with an antibody against guinea pig albumin, the megakaryocytes showed distinctly granular staining throughout the cytoplasm (Fig. 1 a) . Several other cell types, including endothelial cells, also showed staining; they are summarized in Table I .
Human albumin. Injected human albumin was detected in the presence of its native counterpart by using an anti-human albumin MAb. Bone marrow from untreated guinea pigs showed no reaction product when stained with this antibody ( Fig. 1 b) ; therefore, it did not crossreact with guinea pig albumin. Furthermore, no crossreactivity was detected by the much more sensitive Western blot technique (not illustrated). In guinea pigs killed 1-6 h after the injection of human albumin, the vast majority ofbone marrow megakaryocytes exhibited uptake of the protein. However, occasional megakaryocytes showed minimal or no staining. The pattern of staining was usually granular, but was occasionally diffuse or membranous. Bone marrow megakaryocytes from guinea pigs killed 24 -96 h after the injection consistently showed extensive staining for human albumin in a distinctly granular pattern (Fig. 1 c) of the experiments a total of 1 g of albumin was injected. However, even when the animal received the small (100 mg) dose of human albumin, megakaryocytes stained for the injected protein but with less intensity (not illustrated).
At 1-6 h after the injection, and to a lesser degree at later periods, staining of intercellular spaces for human albumin was observed within the marrow, and in small amounts in bone marrow fibroblasts, osteoblasts, fat cells, and an occasional blast. Sinus endothelial cells consistently stained for human albumin (Fig. 1 c) . Some bone marrow macrophages also appeared to take up human albumin. This staining seems to be specific, because the endogenous peroxidase activity of neutrophils, eosinophils, and red cells was completely inhibited.
Biotinylated guinea pig albumin. To test the possibility of differences in uptake of heterologous human albumin and homologous albumin by guinea pig megakaryocytes, we compared the uptake of injected biotinylated guinea pig and human albumin. Both proteins were taken up by megakaryocytes. Megakaryocytes from animals given 175 mg of biotinylated guinea pig albumin and killed 24 h after injection showed relatively weak staining (Fig. 1 d) . When the dose was < 50 mg, biotinylated albumin could not be detected. No difference in uptake of homologous and heterologous albumin could be detected by immunohistochemical techniques.
Electron microscopic localization of biotinylated albumin. When stained for biotin-labeled guinea pig albumin, megakaryocytes collected as early as 2 h after injection contained numerous electron-opaque granules (not illustrated). At 24 h after injection the majority of megakaryocyte granules contained biotin-labeled albumin (Fig. 2 a) . Some granules were negative and granules varied in staining intensity at both 2 and 24 h. Occasional megakaryocytes lacking stained granules were seen at both time intervals.
In control experiments megakaryocytes from untreated guinea pigs processed and stained identically showed no reactivity (Fig. 2 b) . IgG Native IgG. When stained with anti-guinea pig IgG antibody, bone marrow megakaryocytes from untreated guinea pigs showed a granular staining pattern (Fig. 1 e) . Plasma cells showed strong staining as expected. Fat cells occasionally showed staining. These findings are summarized in Table I .
Human IgG. Injected human IgG was detected in the presence of native IgG using a non-crossreacting antibody.
No crossreactivity of the adsorbed antibody with guinea pig IgG was observed, and bone marrow from untreated guinea pigs was completely negative when stained with this goat anti-human IgG antibody (Fig. 1 f) .
In bone marrow from guinea pigs killed 24 h after the injection of human IgG megakaryocytes showed staining in a granular distribution pattern (Fig. 1 g) but varying in intensity among cells. Sinus endothelial cells exhibited small but consistent staining. Occasional bone marrow macrophages and fibroblasts also showed staining. The absence of staining in plasma cells confirmed that the antibody did not crossreact with guinea pig IgG. Moderate amounts of staining were present in extracellular spaces in bone marrow (Fig. 1 g) .
Biotinylated guinea pig IgG. When homologous biotinylated IgG was injected, the labeled protein was detected in megakaryocytes after 24 h (not illustrated). 'ArL Fibrinogen Native fibrinogen. We used a rabbit anti-human fibrinogen polyclonal antibody that crossreacts with guinea pig fibrinogen to study the normal distribution of native fibrinogen. Megakaryocytes stained strongly for fibrinogen, which showed a granular distribution (Fig. 1 h) . There was marked variability between megakaryocytes. The differences were more obvious at higher dilutions (1:5,000 and 1:10,000) of anti-fibrinogen antibody, where even a few negative megakaryocytes could be seen. However, these differences disappeared to a large extent with lower anti-fibrinogen antibody dilutions (1:500), similar to that used in the present study. At this dilution, although the variable staining between megakaryocytes persisted, almost all megakaryocytes stained for fibrinogen. Bone marrow endothelial cells, some macrophages, and an occasional fat cell also stained for fibrinogen (Table I) .
Humanfibrinogen. We abandoned the use of heterologous protein to study megakaryocyte uptake of fibrinogen because the antibodies to human fibrinogen that we tested crossreacted with guinea pig fibrinogen.
Biotinylated guinea pig fibrinogen. Biotinylated homologous fibrinogen was detected in megakaryocytes 24 h after injection. Staining for the labeled protein was distributed in a granular pattern (not illustrated).
Biotinylated humanfibrinogen. We observed no significant difference between guinea pig and human fibrinogen in uptake by guinea pig megakaryocytes. Therefore, we used human fibrinogen in the majority of experiments because large amounts of the pure human protein were available.
As early as 2 h after biotinylated fibrinogen was injected, the label could be localized in megakaryocytes. At this time, the staining was often membranous (not illustrated). Megakaryocytes from animals killed 24 h after injection showed staining (Fig. 1 i) , usually in a striking granular distribution, but occasionally along the membranes. Variation in staining intensity among megakaryocytes suggested that uptake was not uniform. In animals killed 48 h after injection, the staining was slightly less intense than at 24 h.
Sinus endothelial cells often showed weak staining for labeled fibrinogen. Bone marrow macrophages occasionally showed staining.
In a few experiments streptavidin-conjugated HRP was used as the primary reagent instead of the anti-biotin antibody. The weaker staining with this reagent demonstrated that the anti-biotin antibody was more sensitive.
In control experiments for biotinylated proteins, bone marrow from untreated guinea pigs and animals given unconjugated biotin showed no reaction when stained with antibiotin antibody. In other experiments, where normal rabbit or mouse serum was substituted for primary antibody or secondary reagents were eliminated, no reaction product was present.
Human lactoferrin. When stained with rabbit anti-human lactoferrin, bone marrow from the animal given lactoferrin showed staining of some sinus endothelium and marrow macrophages. Megakaryocytes showed complete absence of staining (not illustrated). Neutrophilic myelocytes and more mature cells consistently stained in a granular pattern. In control experiments marrow from untreated animals, when stained with anti-lactoferrin antibody, only the neutrophils were stained, showing that the antibody crossreacted with guinea pig lactoferrin.
Platelets
Based on our findings that plasma proteins such as albumin and fibrinogen are endocytosed by megakaryocytes, one would expect the presence of injected biotinylated proteins in peripheral blood platelets. Blood samples were obtained 2 and 24 h after injection of fibrinogen, and the platelets were isolated, washed, and examined for biotinylated fibrinogen. Western blot analysis of platelets showed that biotinylated fibrinogen was present in the supernatant of thrombin-stimulated platelets 24 h after injection consistent with secretion from platelet storage granules (Fig. 3, lane 1) . In contrast, biotinylated fibrinogen was present in the platelet pellet (lane 5), but not in the supernatant of platelets that were not stimulated with thrombin 24 h after injection of biotinylated fibrinogen. A small amount of biotinylated fibrinogen was associated with the platelet pellet in the 2-h sample (lane 3). It is unclear as to the nature of the fibrinogen since it was not secreted with thrombin stimulation. In other experiments no labeled fibrinogen was seen in either the 2-h platelet supernatant or pellets (data not shown). The results also indicate that endocytosed biotin-labeled fibrinogen is secreted intact (Mr 340,000).
Immunocytochemical staining for biotin-labeled albumin showed that the vast majority ofplatelets 2 h after injection do not contain the injected protein (Fig. 4 a) , although a few platelets containing stainable granules were seen (not illustrated). However, 24 h after injection the majority of platelets contained granules that stained for labeled albumin (Fig. 4 b) . Quantitation was difficult on electron micrographs due to the numerous grazing sections of platelets that showed few or no granules. At the light microscopic level > 80% ofplatelets at 24 h stained for injected labeled proteins. There was marked variability in the staining intensity among these platelets.
When platelets were double labeled, using protein AS to label injected biotinylated fibrinogen and protein A1O to label endogenous albumin, both sizes of gold were present within the same granules (Fig. 4 c) . This demonstrates that the endocytosed fibrinogen is indeed within a-granules. Granules in 4a 0. No reactivity is seen in platelet granules (arrows). X37,000. (b) Section of platelet isolated 24 h after the injection of biotin-labeled albumin. Many platelet granules are strongly reactive. A few negative granules can also be seen (arrows). Two platelet sections in which granules are absent can also be seen. X37,000. (c) Double-labeling for biotin and endogenous albumin on a frozen thin section of platelet obtained 24 h after injecting biotin-labeled fibnnogen. Colocalization of small gold probe for biotin-labeled fibrinogen (arrowheads) and large gold probe for guinea pig albumin (arrows) within granules can be clearly seen. m, mitochondria. X92 tent with the recent observation that the platelet a-granule content of IgG and albumin is directly proportional to the plasma concentration of these proteins (21 (22) . It could, therefore, be argued that uptake of plasma proteins by megakaryocytes may not be physiological. For this reason we performed other experiments using lower concentrations of plasma proteins. Although less intense, staining for injected protein was easily observed in megakaryocytes when considerably smaller doses of both biotinylated and heterologous proteins were injected. However, at doses of < 50 mg, the injected biotinylated protein was difficult to detect, perhaps because of a sensitivity threshold of the immunohistochemical technique.
In a previous study HRP that had been injected into guinea pigs was seen in coated vesicles in megakaryocytes and subsequently in a-granules (14, 15) . A similar pathway may be involved in the uptake of plasma proteins by megakaryocytes. The uptake and incorporation ofexogenous protein into granules of other cell types, such as basophils, mast cells, and granule-containing lymphocytes, has been previously demonstrated (23, 24) .
We also detected injected albumin, IgG, and fibrinogen in bone marrow cells other than megakaryocytes. For (43) . Very little is present on the surface (44) (45) (46) . Recently it has been shown that IgG is stored in a-granules and is secreted by stimulated platelets (18) . Since there are no reports of megakaryocyte synthesis of IgG, it was suggested that IgG might be acquired from the plasma and transported to the megakaryocyte agranules (18) . Our present observations support this hypothesis.
Megakaryocytes reside in proximity to vascular sinuses (47). This anatomical location may facilitate uptake of circulating proteins. The mechanisms for protein uptake by megakaryocytes are unknown. Injected human lactoferrin was not seen in megakaryocytes, in contrast to albumin and fibrinogen which were injected in smaller amounts. Based on this single observation, megakaryocyte uptake of circulating proteins appears to have specificity. Megakaryocytes have not been examined for an albumin receptor (48). However, megakaryocytes (49) do contain the fibrinogen receptor, glycoproteins IIb-IIIa.
It is not known whether GPIIb-IIIa is involved in fibrinogen uptake by megakaryocytes. It is interesting that some patients with Glanzmann's thrombasthenia, who are deficient in GPIIb-IIIa, have an unexplained deficiency of platelet fibrinogen (7) . Megakaryocytes and platelets also contain an Fc receptor that may play a role in receptor-mediated endocytosis of IgG (50) . However, cells can also take up substances by nonspecific fluid phase mechanisms independent of receptors (51).
Our study does not address whether megakaryocytes synthesize plasma proteins. Although synthesis of IgG by megakaryocytes has not been demonstrated, fibrinogen has been shown to be synthesized by megakaryocytes (9-11). Therefore, it appears that both endogenous synthesis and endocytosis of circulating proteins synthesized by other tissues may contribute to megakaryocyte granule composition.
